Published in Inflammation on November 19, 2016
Bioavailability of curcumin: problems and promises. Mol Pharm (2007) 8.72
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Integrating mechanisms of pulmonary fibrosis. J Exp Med (2011) 3.57
The mechanics of airway narrowing in asthma. Am Rev Respir Dis (1989) 3.21
Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol (2003) 3.15
Pathogenesis of asthma. Clin Exp Allergy (2008) 2.93
Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol (2002) 2.83
Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 2.51
The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis (1993) 2.23
Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med (2000) 2.18
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol (1998) 1.62
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53
Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 1.51
Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res (2005) 1.48
The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett (2007) 1.45
A role for eosinophils in airway remodelling in asthma. Trends Immunol (2004) 1.44
Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med (1999) 1.43
Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol (2007) 1.41
Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 1.37
Airway remodeling in asthma. Allergol Int (2007) 1.36
Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res (2001) 1.31
Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent. Am J Pathol (1999) 1.28
A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol (2009) 1.26
Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol (2014) 1.22
Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol (2003) 1.20
Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol (2000) 1.10
The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. J Allergy Clin Immunol (2005) 1.03
Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest (1999) 1.00
Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin Exp Pharmacol Physiol (2001) 0.99
Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells. J Biol Chem (1992) 0.98
Drugs for asthma. Br J Pharmacol (2006) 0.94
Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol (1999) 0.94
Expression of matrix metalloproteinases MMP-9 within the airways in asthma. Respir Med (2003) 0.93
Intranasal curcumin and its evaluation in murine model of asthma. Int Immunopharmacol (2013) 0.79
Intranasal curcumin attenuates airway remodeling in murine model of chronic asthma. Int Immunopharmacol (2014) 0.78
Mepacrine treatment attenuates allergic airway remodeling segregated from airway inflammation in mice. Int Immunopharmacol (2010) 0.76
[Role of eotaxin in the pathophysiology of asthma]. Pneumonol Alergol Pol (2007) 0.76
Protective effects of intranasal curcumin on paraquot induced acute lung injury (ALI) in mice. Environ Toxicol Pharmacol (2014) 0.76
Curcumin inhibits paraquat induced lung inflammation and fibrosis by extracellular matrix modifications in mouse model. Inflammopharmacology (2016) 0.76
Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-α and TGF-β1) in murine model. Inflammopharmacology (2017) 0.75